Mark A. Buthman
CIK: 0001223783
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About BUTHMAN MARK A
BUTHMAN MARK A (SEC CIK 0001223783) files insider reports with the SEC as Director of IDEX CORP /DE/ (IEX) and Director of WEST PHARMACEUTICAL SERVICES INC (WST).
Signal8 holds 4 ownership filings by BUTHMAN MARK A, all Form 4s, filed between May 8, 2025 and May 8, 2026. Those filings report 4 transactions, from May 6, 2025 to May 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BUTHMAN MARK A's filings is in EXTON, PA.
Recent filings by BUTHMAN MARK A
Other insiders filing for IDEX CORP /DE/ (IEX)
- Tereso Tara M., Group Executive, HST
- Simmons William L., Group Executive, FMT & FSDP
- Lausas Allison S, VP, Chief Accounting Officer
- Anderson Lisa M, SVP, GC, CAO & Corp Sec
- ASHLEMAN ERIC D, CEO and President
- Watts Stanfield Paris, Director